Related Experiment Video
Updated: Jun 8, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Laparoscopic bilateral retroperitoneal lymph node dissection in stage II testis cancer
Abbas Basiri1, Mohammad Asl-Zare, Mehrdad Mohammadi Sichani
1Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University, MC, Tehran, Iran. basiri@unrc.ir
Urology Journal
|September 17, 2010
Summary
Laparoscopic bilateral retroperitoneal lymph node dissection (RPLND) is a safe and efficient procedure for stage II testis cancer. This minimally invasive approach avoids patient repositioning and contralateral trocar placement, simplifying the surgery.
Area of Science:
- Urology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Testis cancer management often involves retroperitoneal lymph node dissection (RPLND).
- Laparoscopic techniques are increasingly explored for RPLND to minimize invasiveness.
- Stage II testis cancer may require RPLND, particularly for residual masses post-chemotherapy.
Purpose of the Study:
- To evaluate the feasibility and safety of laparoscopic bilateral RPLND in patients with stage II testis cancer.
- To assess the technical aspects and outcomes of this minimally invasive approach.
Main Methods:
- Retrospective review of 4 patients with stage II testis cancer undergoing laparoscopic bilateral RPLND between 2002 and 2009.
- Procedure performed without patient repositioning.
- Utilized a bowel retractor for contralateral dissection.
Main Results:
- The laparoscopic bilateral RPLND was performed uneventfully in all 4 patients.
- No major perioperative complications were reported.
- Contralateral dissection was successfully managed without repositioning.
Conclusions:
- Laparoscopic bilateral RPLND is an efficient and safe surgical option for stage II testis cancer.
- The technique can be performed without patient repositioning or contralateral trocar placement.
- This approach offers a minimally invasive alternative for RPLND in select testis cancer patients.
